Format
Sort by
Items per page

Send to

Choose Destination

Best matches for prostatic phyllodes:

Search results

Items: 1 to 20 of 96

1.

Phyllodes Tumor of the Prostate With Epithelial Intestinal Metaplasia.

Olivas AD, Taxy J, Wolsky R, Antic T.

Am J Surg Pathol. 2018 Jun;42(6):836-839. doi: 10.1097/PAS.0000000000001052.

PMID:
29543676
2.

Does Prophylactic Radiation Therapy to Avoid Gynecomastia in Patients With Prostate Cancer Increase the Risk of Breast Cancer?

Aksnessæther BY, Solberg A, Klepp OH, Myklebust TÅ, Skovlund E, Hoff SR, Vatten LJ, Lund JÅ.

Int J Radiat Oncol Biol Phys. 2018 May 1;101(1):211-216. doi: 10.1016/j.ijrobp.2018.01.096. Epub 2018 Feb 5.

PMID:
29534900
3.

Whole-exome sequencing demonstrates recurrent somatic copy number alterations and sporadic mutations in specialized stromal tumors of the prostate.

Pan CC, Tsuzuki T, Morii E, Fushimi H, Chen PC, Epstein JI.

Hum Pathol. 2018 Jun;76:9-16. doi: 10.1016/j.humpath.2017.12.004. Epub 2017 Dec 16.

PMID:
29258903
4.

Imatinib Spares cKit-Expressing Prostate Neuroendocrine Tumors, whereas Kills Seminal Vesicle Epithelial-Stromal Tumors by Targeting PDGFR-β.

Jachetti E, Rigoni A, Bongiovanni L, Arioli I, Botti L, Parenza M, Cancila V, Chiodoni C, Festinese F, Bellone M, Tardanico R, Tripodo C, Colombo MP.

Mol Cancer Ther. 2017 Feb;16(2):365-375. doi: 10.1158/1535-7163.MCT-16-0466. Epub 2016 Dec 15.

5.

Male Malignant Phyllodes Breast Tumor After Prophylactic Breast Radiotherapy and Bicalutamide Treatment: A Case Report.

Karihtala P, Rissanen T, Tuominen H.

Anticancer Res. 2016 Jul;36(7):3433-6.

PMID:
27354604
6.

Round cell pattern of prostatic stromal tumor of uncertain malignant potential: a subtle newly recognized variant.

Sadimin ET, Epstein JI.

Hum Pathol. 2016 Jun;52:68-73. doi: 10.1016/j.humpath.2016.01.002. Epub 2016 Feb 1.

PMID:
26980017
7.

Somatic MED12 mutations in prostate cancer and uterine leiomyomas promote tumorigenesis through distinct mechanisms.

Kämpjärvi K, Kim NH, Keskitalo S, Clark AD, von Nandelstadh P, Turunen M, Heikkinen T, Park MJ, Mäkinen N, Kivinummi K, Lintula S, Hotakainen K, Nevanlinna H, Hokland P, Böhling T, Bützow R, Böhm J, Mecklin JP, Järvinen H, Kontro M, Visakorpi T, Taipale J, Varjosalo M, Boyer TG, Vahteristo P.

Prostate. 2016 Jan;76(1):22-31. doi: 10.1002/pros.23092. Epub 2015 Sep 18.

PMID:
26383637
8.

Phyllodes tumor of the verumontanum: a case report.

Tang J, He L, Long Z, Wei J.

Diagn Pathol. 2015 Jun 16;10:69. doi: 10.1186/s13000-015-0314-0.

9.

Mixed epithelial-stromal tumor (MEST) of seminal vesicle: a proposal for unified nomenclature.

Reikie BA, Yilmaz A, Medlicott S, Trpkov K.

Adv Anat Pathol. 2015 Mar;22(2):113-20. doi: 10.1097/PAP.0000000000000057. Review.

PMID:
25664946
10.

The steroid receptor coactivator-3 is required for developing neuroendocrine tumor in the mouse prostate.

Tien JC, Liao L, Liu Y, Liu Z, Lee DK, Wang F, Xu J.

Int J Biol Sci. 2014 Oct 2;10(10):1116-27. doi: 10.7150/ijbs.10236. eCollection 2014.

11.

Onset of hydronephrosis and lower urinary tract symptoms in a previously healthy young man: Phyllodes tumour of the prostate as a potential diagnosis.

Ferrari M, Capitanio U, Rizzo N, Freschi M, Montorsi F, Rigatti P.

Can Urol Assoc J. 2014 Jul;8(7-8):E561-3. doi: 10.5489/cuaj.1984.

12.

Benign phyllodes tumour of the prostate: An extremely rare entity.

Aydogdu O, Atesci YZ, Karakose A, Demirtas E.

Can Urol Assoc J. 2014 Jul;8(7-8):E548-51. doi: 10.5489/cuaj.2030.

13.

[Prostatic stromal tumors of uncertain malignant potential (STUMP): a case report].

Michaud S, Moreau A, Braud G, Renaudin K, Branchereau J, Bouchot O, Rigaud J.

Ann Pathol. 2014 Jun;34(3):233-6. doi: 10.1016/j.annpat.2014.03.008. Epub 2014 May 22. French.

PMID:
24950874
14.

Multidisciplinary treatment including systemic chemotherapy for a malignant phyllodes tumour of the prostate.

Murakami Y, Tabata K, Sugita A, Mochizuki K, Maeyama R, Okazaki M, Nishi M, Matsumoto K, Fujita T, Satoh T, Jiang SX, Saegusa M, Iwamura M.

Can Urol Assoc J. 2014 Mar;8(3-4):E263-5. doi: 10.5489/cuaj.1648.

15.

Extra-prostatic transgene-associated neoplastic lesions in transgenic adenocarcinoma of the mouse prostate (TRAMP) mice.

Berman-Booty LD, Thomas-Ahner JM, Bolon B, Oglesbee MJ, Clinton SK, Kulp SK, Chen CS, La Perle KM.

Toxicol Pathol. 2015 Feb;43(2):186-97. doi: 10.1177/0192623314531351. Epub 2014 Apr 17.

16.

Cystosarcoma phyllodes of the seminal vesicle: a case report and literature review.

Olivetti L, Laffranchi F, De Luca V.

Case Rep Urol. 2014;2014:302708. doi: 10.1155/2014/302708. Epub 2014 Jan 2.

17.

Common chromosomal aberrations detected by array comparative genomic hybridization in specialized stromal tumors of the prostate.

Pan CC, Epstein JI.

Mod Pathol. 2013 Nov;26(11):1536-43. doi: 10.1038/modpathol.2013.99. Epub 2013 Jun 14.

18.

FGFR1 is essential for prostate cancer progression and metastasis.

Yang F, Zhang Y, Ressler SJ, Ittmann MM, Ayala GE, Dang TD, Wang F, Rowley DR.

Cancer Res. 2013 Jun 15;73(12):3716-24. doi: 10.1158/0008-5472.CAN-12-3274. Epub 2013 Apr 10.

19.

Anal phyllodes tumor in a male patient: a unique case presentation and literature review.

Ho SP, Tseng HH, King TM, Chow PC.

Diagn Pathol. 2013 Mar 26;8:49. doi: 10.1186/1746-1596-8-49.

20.

The Rare Cancer Network: achievements from 1993 to 2012.

Patel A, Ozsahin M, Mirimanoff RO, Bhatia S, Chang K, Miller RC.

Rare Tumors. 2012 Jun 26;4(3):e35. doi: 10.4081/rt.2012.e35. Epub 2012 Sep 27.

Supplemental Content

Loading ...
Support Center